Drug Shortage Report for TEVA-NABILONE
Report ID | 109607 |
Drug Identification Number | 02384884 |
Brand name | TEVA-NABILONE |
Common or Proper name | NABILONE 0.5MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-25 |
Estimated end date | 2020-09-30 |
Actual end date | 2020-09-09 |
Shortage status | Resolved |
Updated date | 2020-09-10 |
Company comments | Allocating to 100% of our market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2020-09-10 | French | Compare |
v17 | 2020-09-10 | English | Compare |
v16 | 2020-07-09 | French | Compare |
v15 | 2020-07-09 | English | Compare |
v14 | 2020-06-18 | French | Compare |
v13 | 2020-06-18 | English | Compare |
v12 | 2020-06-04 | French | Compare |
v11 | 2020-06-04 | English | Compare |
v10 | 2020-05-08 | French | Compare |
v9 | 2020-05-08 | English | Compare |
v8 | 2020-04-23 | French | Compare |
v7 | 2020-04-23 | English | Compare |
v6 | 2020-04-16 | French | Compare |
v5 | 2020-04-16 | English | Compare |
v4 | 2020-04-02 | French | Compare |
v3 | 2020-04-02 | English | Compare |
v2 | 2020-03-26 | French | Compare |
v1 | 2020-03-26 | English | Compare |
Showing 1 to 18 of 18